Bacterial complement evasion
- PMID: 16875737
- DOI: 10.1016/j.molimm.2006.06.011
Bacterial complement evasion
Abstract
The human complement system is elemental to recognize bacteria, opsonize them for handling by phagocytes, or kill them by direct lysis. However, successful bacterial pathogens have in turn evolved ingenious strategies to overcome this part of the immune system. In this review we discuss the different stages of complement activation sequentially and illustrate the immune evasion strategies that various bacteria have developed to evade each subsequent step. The focus is on bacterial proteins, either surface-bound or excreted, that block complement activation. The underlying molecular mechanism of action and the possible role in pathophysiology of bacterial infections are discussed.
Similar articles
-
Staphylococcal complement inhibitor modulates phagocyte responses by dimerization of convertases.J Immunol. 2010 Jan 1;184(1):420-5. doi: 10.4049/jimmunol.0902865. Epub 2009 Nov 30. J Immunol. 2010. PMID: 19949103
-
Complement escape of human pathogenic bacteria by acquisition of complement regulators.Mol Immunol. 2006 Jan;43(1-2):31-44. doi: 10.1016/j.molimm.2005.06.016. Mol Immunol. 2006. PMID: 16011850 Review.
-
Modulation of the activity of the classical complement pathway C3 convertase by surface-bound C3 or C5.J Immunol. 1980 Feb;124(2):520-6. J Immunol. 1980. PMID: 7356706 No abstract available.
-
Complement evasion strategies of pathogens-acquisition of inhibitors and beyond.Mol Immunol. 2009 Sep;46(14):2808-17. doi: 10.1016/j.molimm.2009.04.025. Epub 2009 May 27. Mol Immunol. 2009. PMID: 19477524 Review.
-
The human alternative complement pathway: biology and immunopathology of activation and regulation.Prog Allergy. 1982;30:193-234. Prog Allergy. 1982. PMID: 7041132 Review. No abstract available.
Cited by
-
Plasminogen binding proteins and plasmin generation on the surface of Leptospira spp.: the contribution to the bacteria-host interactions.J Biomed Biotechnol. 2012;2012:758513. doi: 10.1155/2012/758513. Epub 2012 Oct 15. J Biomed Biotechnol. 2012. PMID: 23118516 Free PMC article.
-
C4BP-IgM protein as a therapeutic approach to treat Neisseria gonorrhoeae infections.JCI Insight. 2019 Dec 5;4(23):e131886. doi: 10.1172/jci.insight.131886. JCI Insight. 2019. PMID: 31661468 Free PMC article.
-
Plant-Microbe Interaction: Mining the Impact of Native Bacillus amyloliquefaciens WS-10 on Tobacco Bacterial Wilt Disease and Rhizosphere Microbial Communities.Microbiol Spectr. 2022 Aug 31;10(4):e0147122. doi: 10.1128/spectrum.01471-22. Epub 2022 Aug 1. Microbiol Spectr. 2022. PMID: 35913211 Free PMC article.
-
Recognition of LPS by TLR4: potential for anti-inflammatory therapies.Mar Drugs. 2014 Jul 23;12(7):4260-73. doi: 10.3390/md12074260. Mar Drugs. 2014. PMID: 25056632 Free PMC article.
-
Complement evasion by human pathogens.Nat Rev Microbiol. 2008 Feb;6(2):132-42. doi: 10.1038/nrmicro1824. Nat Rev Microbiol. 2008. PMID: 18197169 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical